For families and patients wanting more information about Allo Phase 2 Clinical Trial: LEARN MORE

For symptomatic peri- and post menopausal women interested in information regarding clinical trial to test the safety and efficacy of PhytoSERM, a potential alternative to hormone therapy. LEARN MORE

Building a Resilient Brain To Prevent Alzheimer’s Disease

The bioenergetic changes that occur with the aging brain are at the heart of new research.

A new research study led by Fei Yin, PhD, and funded by a $1.1 million grant from the National Institutes of Health, will help determine the role of an Alzheimer’s risk-factor gene in regulating the brain energy production system.





The Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.

© 2023 Center for Innovation Brain Science. University of Arizona Health Sciences.

Skip to content